The week of 2025-07-01, 17 holders filed a new Schedule 13D and 42 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-07-03 | Pelthos Therapeutics Inc. | Ligand Pharmaceuticals Incorporated | 49.9% | SCHEDULE 13D |
| 2025-07-03 | MediaCo Holding Inc. | BlackRock Portfolio Management LLC | 46.1% | SCHEDULE 13D |
| 2025-07-01 | Clearone Inc | First Finance Ltd. | 32.4% | SCHEDULE 13D |
| 2025-07-03 | Yorkville Acquisition Corp. | Yorkville Acquisition Sponsor LLC | 25.88% | SCHEDULE 13D |
| 2025-07-01 | Cantor Equity Partners Iii, Inc. | Cantor EP Holdings III, LLC | 21.3% | SCHEDULE 13D |
| 2025-07-01 | Grown Rogue International Inc. | Bengal Catalyst Fund, LP | 11.8% | SCHEDULE 13D |
| 2025-07-01 | Newegg Commerce, Inc. | Galkin Vladimir | 10.8% | SCHEDULE 13D |
| 2025-07-01 | Commercial Vehicle Group, Inc. | Lakeview Opportunity Fund LLC | 9% | SCHEDULE 13D |
| 2025-07-01 | Alaunos Therapeutics, Inc. | Postma Robert W | 9% | SCHEDULE 13D |
| 2025-07-03 | Tripadvisor, Inc. | Starboard Value LP | 9% | SCHEDULE 13D |
| 2025-07-02 | Universal Safety Products, Inc. | JLA Realty Associates, LLC | 8.8% | SCHEDULE 13D |
| 2025-07-03 | AppTech Payments Corp. | Albert L. Lord | 8.5% | SCHEDULE 13D |
| 2025-07-03 | Cimpress plc | Spruce House Investment Management LLC | 8.35% | SCHEDULE 13D |
| 2025-07-01 | Investec PLC | Standard Bank Of South Africa Ltd | 6.7% | SCHEDULE 13D |
| 2025-07-03 | Investec PLC | Standard Bank Of South Africa Ltd | 5.5% | SCHEDULE 13D |
| 2025-07-03 | Barnwell Industries Inc | Barnwell Industries, Inc. Employees' Pension Plan Trust | 5.2% | SCHEDULE 13D |
| 2025-07-01 | Truworths International Ltd | Standard Bank Of South Africa Ltd | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-07-02 | iShares High Yield Active ETF | BlackRock Portfolio Management LLC | 100% | SCHEDULE 13G |
| 2025-07-02 | iShares MSCI UAE ETF | BlackRock Portfolio Management LLC | 55.6% | SCHEDULE 13G |
| 2025-07-02 | Perfect Moment Ltd. | Bard Associates Inc | 16.4% | SCHEDULE 13G |
| 2025-07-02 | Ralliant Corporation | BlackRock, Inc. | 14.5% | SCHEDULE 13G |
| 2025-07-02 | Hennessy Sustainable Etf | BlackRock Portfolio Management LLC | 14.4% | SCHEDULE 13G |
| 2025-07-02 | Methanex Corporation | Oci N.V. | 12.9% | SCHEDULE 13G |
| 2025-07-02 | Grupo Cibest S.A. | BlackRock, Inc. | 12.4% | SCHEDULE 13G |
| 2025-07-01 | Linkage Global Inc | Zhiqiang Li | 12.2% | SCHEDULE 13G |
| 2025-07-01 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 11.9% | SCHEDULE 13G |
| 2025-07-02 | Allied Gold Corp | BlackRock Portfolio Management LLC | 11% | SCHEDULE 13G |
| 2025-07-02 | Oragenics Inc | Five Narrow Lane LP | 9.99% | SCHEDULE 13G |
| 2025-07-03 | Ascent Solar Technologies, Inc. | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2025-07-03 | Bone Biologics Corporation | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2025-07-01 | Nano Labs Ltd | CVI Investments, Inc. | 9.9% | SCHEDULE 13G |
| 2025-07-01 | Enzo Biochem Inc | Beryl Capital Management LLC | 9.7% | SCHEDULE 13G |
| 2025-07-03 | Invesco Equal Weight 0-30 Year Treasury ETF | AdvisorShares Trust | 9.68% | SCHEDULE 13G |
| 2025-07-02 | Greenland Mines Ltd | Austria Capital LLC | 9.41% | SCHEDULE 13G |
| 2025-07-01 | Surf Air Mobility Inc. | CVI Investments, Inc. | 9.2% | SCHEDULE 13G |
| 2025-07-02 | New Horizon Aircraft Ltd. | Brumder William George | 8.6% | SCHEDULE 13G |
| 2025-07-03 | Wintergreen Acquisition Corp. | Feis Equities LLC | 8.44% | SCHEDULE 13G |
| 2025-07-03 | Eureka Acquisition Corp | Feis Equities LLC | 8.26% | SCHEDULE 13G |
| 2025-07-03 | Sintx Technologies Inc | Sinaptic Holdings, LLC | 7.9% | SCHEDULE 13G |
| 2025-07-03 | DNA X, Inc. | CVI Investments, Inc. | 7.3% | SCHEDULE 13G |
| 2025-07-02 | TMC the metals Co Inc. | Korea Zinc Company, Ltd. | 7.2% | SCHEDULE 13G |
| 2025-07-01 | Ww International, Inc. | Arini Capital Management Limited | 6.4% | SCHEDULE 13G |
| 2025-07-03 | RiverNorth Capital & Income Fund, Inc. | Css LLC | 6.31% | SCHEDULE 13G |
| 2025-07-01 | Smartrent, Inc. | John Helm | 6.2% | SCHEDULE 13G |
| 2025-07-03 | Linkage Global Inc | Suide Zheng | 6.1% | SCHEDULE 13G |
| 2025-07-01 | Reviva Pharmaceuticals Holdi | CVI Investments, Inc. | 5.9% | SCHEDULE 13G |
| 2025-07-03 | Yorkville Acquisition Corp. | Harraden Circle Investments, LLC | 5.73% | SCHEDULE 13G |
| 2025-07-01 | Pyxis Oncology, Inc. | Millennium Management LLC | 5.7% | SCHEDULE 13G |
| 2025-07-02 | Modular Medical, Inc. | Bard Associates Inc | 5.6% | SCHEDULE 13G |
| 2025-07-01 | Viemed Healthcare, Inc. | Forager Capital Management, LLC | 5.5% | SCHEDULE 13G |
| 2025-07-02 | INmune Bio Inc. | CVI Investments, Inc. | 5.5% | SCHEDULE 13G |
| 2025-07-02 | Cidara Therapeutics, Inc. | Commodore Capital LP | 5.5% | SCHEDULE 13G |
| 2025-07-02 | Research Solutions, Inc. | Poplar Point Capital Management LLC | 5.48% | SCHEDULE 13G |
| 2025-07-03 | Daktronics Inc | Progeny 3, Inc. | 5.4% | SCHEDULE 13G |
| 2025-07-03 | Nektar Therapeutics | Millennium Management LLC | 5.4% | SCHEDULE 13G |
| 2025-07-01 | Turning Point Brands, Inc. | Divisadero Street Capital Management, LP | 5.3% | SCHEDULE 13G |
| 2025-07-01 | Vanda Pharmaceuticals Inc. | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2025-07-01 | OmniAb, Inc. | Robert Goldstein | 5.3% | SCHEDULE 13G |
| 2025-07-03 | Taysha Gene Therapies, Inc. | The Goldman Sachs Group, Inc. | 5.1% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.